Alyeska Investment Group
LCTX icon

Alyeska Investment Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Alyeska Investment Group’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,947,369
Closed -$1.98M – 590
2024
Q4 		$1.98M Buy
+3,947,369
New +$1.98M 0.01% 464